Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination.
Tea F, Lopez JA, Ramanathan S, Merheb V, Lee FXZ, Zou A, Pilli D, Patrick E, van der Walt A, Monif M, Tantsis EM, Yiu EM, Vucic S, Henderson APD, Fok A, Fraser CL, Lechner-Scott J, Reddel SW, Broadley S, Barnett MH, Brown DA, Lunemann JD, Dale RC, Brilot F; Australasian and New Zealand MOG Study Group. Tea F, et al. Acta Neuropathol Commun. 2019 Sep 3;7(1):145. doi: 10.1186/s40478-019-0786-3. Acta Neuropathol Commun. 2019. PMID: 31481127 Free PMC article.
Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse.
Trewin BP, Dale RC, Qiu J, Chu M, Jeyakumar N, Dela Cruz F, Andersen J, Siriratnam P, Ma KKM, Hardy TA, van der Walt A, Lechner-Scott J, Butzkueven H, Broadley SA, Barnett MH, Reddel SW, Brilot F, Kalincik T, Ramanathan S; Australasian MOGAD Study Group. Trewin BP, et al. J Neurol Neurosurg Psychiatry. 2024 May 16:jnnp-2024-333463. doi: 10.1136/jnnp-2024-333463. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 38744459 Free article.
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series.
Yule MS, Thompson J, Leesahatsawat K, Sousa MS, Anker SD, Arends J, Balstad TR, Brown LR, Bye A, Dajani O, Fallon M, Hjermstad MJ, Jakobsen G, McDonald J, McGovern J, Roeland EJ, Sayers J, Skipworth RJE, Ottestad IO, Philips I, Simpson MR, Solheim TS, Vagnildhaug OM, McMillan D, Laird BJA, Dolan RD; Cancer Cachexia Endpoints Working Group. Yule MS, et al. Among authors: bye a. J Cachexia Sarcopenia Muscle. 2024 May 23. doi: 10.1002/jcsm.13491. Online ahead of print. J Cachexia Sarcopenia Muscle. 2024. PMID: 38783477 Free article. Review.
Cohort profile: The Social media, smartphone use and Self-harm in Young People (3S-YP) study-A prospective, observational cohort study of young people in contact with mental health services.
Bye A, Carter B, Leightley D, Trevillion K, Liakata M, Branthonne-Foster S, Cross S, Zenasni Z, Carr E, Williamson G, Vega Viyuela A, Dutta R. Bye A, et al. PLoS One. 2024 May 22;19(5):e0299059. doi: 10.1371/journal.pone.0299059. eCollection 2024. PLoS One. 2024. PMID: 38776261 Free PMC article.
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series.
Brown LR, Sousa MS, Yule MS, Baracos VE, McMillan DC, Arends J, Balstad TR, Bye A, Dajani O, Dolan RD, Fallon MT, Greil C, Hjermstad MJ, Jakobsen G, Maddocks M, McDonald J, Ottestad IO, Phillips I, Sayers J, Simpson MR, Vagnildhaug OM, Solheim TS, Laird BJA, Skipworth RJE; ‘Cachexia Endpoint Series Working Group’. Brown LR, et al. Among authors: bye a. J Cachexia Sarcopenia Muscle. 2024 May 13. doi: 10.1002/jcsm.13478. Online ahead of print. J Cachexia Sarcopenia Muscle. 2024. PMID: 38738581 Free article. Review.
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series.
Hjermstad MJ, Jakobsen G, Arends J, Balstad T, Brown LR, Bye A, Coats AJS, Dajani OF, Dolan RD, Fallon MT, Greil C, Grzyb A, Kaasa S, Koteng LH, May AM, McDonald J, Ottestad I, Philips I, Roeland EJ, Sayers J, Simpson MR, Skipworth RJE, Solheim TS, Sousa MS, Vagnildhaug OM, Laird BJA; Cancer Cachexia Endpoints Working Group. Hjermstad MJ, et al. Among authors: bye a. J Cachexia Sarcopenia Muscle. 2024 Mar 29. doi: 10.1002/jcsm.13453. Online ahead of print. J Cachexia Sarcopenia Muscle. 2024. PMID: 38553255 Free article. Review.
402 results